Log in to search using one of your social media accounts:

 

Biosimilars: To Switch or Not to Switch?
The pros and cons of using biosimilar medications shaped the “Great Debate” at this year’s ACR/ARHP Annual Meeting. (Source: CancerNetwork)
Source: CancerNetwork - November 8, 2017 Category: Cancer & Oncology Authors: Mariah Zebrowski Leach, JD, MS Tags: Rheumatoid Arthritis Rheumatic Diseases Source Type: news

Biosimilars: To Switch or Not to Switch?
The pros and cons of using biosimilar medications shaped the “Great Debate” at this year’s ACR/ARHP Annual Meeting. (Source: ConsultantLive)
Source: ConsultantLive - November 7, 2017 Category: Internal Medicine Authors: Mariah Zebrowski Leach, JD, MS Tags: Rheumatoid Arthritis Rheumatic Diseases Source Type: news

Obesity, Rheumatoid Arthritis Linked at ACR Meeting
Obesity is associated with a higher degree of synovitis, lower remission, and higher disability, studies showed. (Source: CancerNetwork)
Source: CancerNetwork - November 7, 2017 Category: Cancer & Oncology Authors: Leo Robert Tags: Rheumatoid Arthritis Source Type: news

Obesity, Rheumatoid Arthritis Linked at ACR Meeting
Obesity is associated with a higher degree of synovitis, lower remission, and higher disability, studies showed. (Source: ConsultantLive)
Source: ConsultantLive - November 7, 2017 Category: Internal Medicine Authors: Leo Robert Tags: Rheumatoid Arthritis Source Type: news

Opioids, SSRIs Boost Fracture Risk in Rheumatoid Arthritis
The increased fracture risk may be the result of an increased risk of falls associated with these medications. (Source: ConsultantLive)
Source: ConsultantLive - November 7, 2017 Category: Internal Medicine Authors: Leo Robert Tags: Rheumatoid Arthritis Source Type: news

Opioids, SSRIs Boost Fracture Risk in Rheumatoid Arthritis
The increased fracture risk may be the result of an increased risk of falls associated with these medications. (Source: CancerNetwork)
Source: CancerNetwork - November 6, 2017 Category: Cancer & Oncology Authors: Leo Robert Tags: Rheumatoid Arthritis Source Type: news

Predicting Successful Biologic Tapering for RA Feasible Predicting Successful Biologic Tapering for RA Feasible
Expensive biologics associated with adverse effects can be reduced in carefully selected patients with rheumatoid arthritis (RA), report Japanese researchers.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 6, 2017 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Efficacy and safety maintained in patients who switched from Humira ® to biosimilar Cyltezo®
Boehringer Ingelheim today announced one-year data from VOLTAIRE®-RA, a pivotal Phase III clinical trial comparing Cyltezo® (adalimumab-adbm) and reference product Humira®*. The 48-week data showed that Cyltezo® is equivalent, with no clinically meaningful differences in efficacy, safety and immunogenicity to Humira® in people with moderately-to-severely active rheumatoid arthritis (RA), including in patients who switched from Humira® to Cyltezo® at week 24. (Source: World Pharma News)
Source: World Pharma News - November 6, 2017 Category: Pharmaceuticals Tags: Featured Boehringer Ingelheim Business and Industry Source Type: news

Stop Methotrexate in RA Patients for 2 Weeks After Flu Shot Stop Methotrexate in RA Patients for 2 Weeks After Flu Shot
A temporary suspension of methotrexate boosts the immune response to flu vaccination with no increase in rheumatoid arthritis (RA) disease activity, a randomized clinical trial shows.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 5, 2017 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Obesity linked to lower remission, higher disability in rheumatoid arthritis patients
(American College of Rheumatology) Patients with rheumatoid arthritis whose body-mass index scores are higher have lower rates of remission and higher rates of disability, and effective weight screening and management should be a central feature of RA management, according to new research findings presented this week at the 2017 ACR/ARHP Annual Meeting in San Diego. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - November 4, 2017 Category: International Medicine & Public Health Source Type: news

Age, CRP levels predict success in tapering of biologics in rheumatoid arthritis patients
(American College of Rheumatology) Rheumatoid arthritis patients in remission may experience more successful tapering of their biologic drugs if they meet a certain set of factors, including younger age, no concomitant steroid use, and low level of serum CRP, according to new research findings presented this week at the 2017 ACR/ARHP Annual Meeting in San Diego. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - November 4, 2017 Category: International Medicine & Public Health Source Type: news

Biologics do not increase the risk of second malignancy in rheumatoid arthritis patients
(American College of Rheumatology) Treatment with biologics does not increase the risk of a second malignancy in rheumatoid arthritis patients who have a history of cancer, according to new research findings presented this week at the 2017 ACR/ARHP Annual Meeting. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 4, 2017 Category: Cancer & Oncology Source Type: news

Psoriasis patients at higher risk for liver disease
Study compares inflammatory illnesses Related items fromOnMedica GPs to get help to boost early detection of liver disease Benefits of exercise training in women with fatty liver disease Psoriasis photo library Rheumatoid arthritis Drug for rheumatoid arthritis appears to have effect on severe eczema (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 3, 2017 Category: UK Health Source Type: news

Rheumatoid Arthritis Linked to Risk of COPD
Title: Rheumatoid Arthritis Linked to Risk of COPDCategory: Health NewsCreated: 10/31/2017 12:00:00 AMLast Editorial Review: 11/1/2017 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - November 1, 2017 Category: Rheumatology Source Type: news

Rheumatoid Arthritis Linked to Risk of COPD
People with rheumatoid arthritis appear to have a higher risk of the lung condition chronic obstructive pulmonary disease (COPD), researchers report. (Source: WebMD Health)
Source: WebMD Health - October 31, 2017 Category: Consumer Health News Source Type: news

Rheumatoid Arthritis Linked to Risk of COPD
TUESDAY, Oct. 31, 2017 -- People with rheumatoid arthritis appear to have a higher risk of the lung condition chronic obstructive pulmonary disease (COPD), researchers report. The study found that people with rheumatoid arthritis were 47 percent... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 31, 2017 Category: General Medicine Source Type: news

Medical News Today: How does rheumatoid arthritis affect the skin?
Rashes only affect a small percentage of people with rheumatoid arthritis. Learn about the symptoms and treatment of rheumatoid arthritis rashes here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 31, 2017 Category: Consumer Health News Tags: Arthritis / Rheumatology Source Type: news

Medicare Monday: CMS withdraws Part B demo, takes positive step forward on CMMI
In case you missed it, earlier this month, the Center for Medicare& Medicaid Services formallywithdrew a controversial proposal that would have had a detrimental impact on patient access to lifesaving treatments covered under Part B, many of which are used to treat complex conditions like cancer, rheumatoid arthritis and mental illness. (Source: The Catalyst)
Source: The Catalyst - October 30, 2017 Category: Pharmaceuticals Tags: Medicare Medicare Monday Part B CMMI Source Type: news

Medical News Today: What are rheumatoid nodules?
A quarter of people with rheumatoid arthritis develop firm lumps under the skin called rheumatoid nodules. Learn about the risk factors and treatment. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 28, 2017 Category: Consumer Health News Tags: Arthritis / Rheumatology Source Type: news

New survey highlights impact of rheumatoid arthritis in the workplace
Rheumatoidarthritis patients are frequently not being provided with the level of support they require from their employers, according to a new report. A survey carried out by the University of Manchester and the NationalRheumatoid Arthritis Society has indicated that many patients feel their bosses are not aware enough of their condition, with many having to change jobs as a consequence of their condition. The challenges faced by arthritis patients at work The survey questioned more than 1,500 people in the UK and found that 39 per cent of patients feel that their employer lacks awareness of rheumatoid arthritis, up from 2...
Source: Arthritis Research UK - October 25, 2017 Category: Rheumatology Source Type: news

Medical News Today: Early signs and symptoms of rheumatoid arthritis
Rheumatoid arthritis is a disorder where a person's immune system attacks their joints, causing them to become inflamed. What are the early signs? (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 25, 2017 Category: Consumer Health News Tags: Arthritis / Rheumatology Source Type: news

BIOCAD enters the European market
The largest Russian biotechnology company BIOCAD plans to enter the European market with oncological and autoimmune medicines. So far, there are seven molecules in the European portfolio of BIOCAD. This are innovative and biosimilar products, which could be used in treatment of melanoma, breast, stomach, kidney and lung cancer, rheumatoid arthritis, psoriasis and multiple sclerosis. (Source: World Pharma News)
Source: World Pharma News - October 25, 2017 Category: Pharmaceuticals Tags: Featured Business Business and Industry Source Type: news

New hydrogel developed to combat rheumatoid arthritis
A new gel-based material has been developed that could help to treat rheumatoidarthritis through a number of modes of action. Researchers from South Korea's Institute for Basic Science have created the gel to detect nitric oxide, a core mechanism that allows the substance to be used to absorb additional fluid from swollen joints, or to release medication to affected areas. How the gel works A report published in the journal Advanced Materials has shown how the gel is able to respond to the overproduction of nitric oxide, which often occurs when immune cells become overactive in inflamed joints. Research leader Kim Won ...
Source: Arthritis Research UK - October 24, 2017 Category: Rheumatology Source Type: news

Medical News Today: Rheumatoid arthritis may raise COPD risk
A new study of 50,000 people finds that those with rheumatoid arthritis had a 47 percent higher risk of COPD hospitalization than the general population. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 23, 2017 Category: Consumer Health News Tags: Arthritis / Rheumatology Source Type: news

Biosimilar drugs could cut US health spending by $54 billion over next decade
(RAND Corporation) Biosimilar drugs have been touted as one strategy to help curb the runaway costs of biologics that have advanced the treatment of illness such as rheumatoid arthritis and many cancers. A new study finds biosimilars could cut health care spending in the United States by $54 billion over the next decade. The savings are about 20 percent larger than a similar, widely cited analysis done three years ago by the same researchers. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 23, 2017 Category: International Medicine & Public Health Source Type: news

Biosimilar Drugs May Reduce U.S. Health Spending by $54 Billion Over Next Decade
Introducing“biosimilar” versions of complex biologic drugs used to treat illnesses such as cancer and rheumatoid arthritis could cut health care spending in the United States by $54 billion over the next decade. (Source: RAND)
Source: RAND - October 23, 2017 Category: Health Management Authors: RAND Corporation Source Type: news

Janssen receives two u.s. fda approvals for simponi aria ® (golimumab) for the treatment of adults with active psoriatic arthritis or active ankylosing spondylitis
SIMPONI ARIA ® is the Only Fully-Human Anti-TNF-alpha Infused Therapy Now Approved for Psoriatic Arthritis, Ankylosing Spondylitis and Rheumatoid Arthritis (Source: Johnson and Johnson)
Source: Johnson and Johnson - October 21, 2017 Category: Pharmaceuticals Source Type: news

Rheumatoid arthritis: Symptoms could be signs of THESE lung diseases
Rheumatoid arthritis symptoms could cause some lung conditions, including emphysema and chronic bronchitis, researchers have warned. (Source: Daily Express - Health)
Source: Daily Express - Health - October 20, 2017 Category: Consumer Health News Source Type: news

Arthritis raises the risk of a deadly lung disease
The 400,000 people with rheumatoid arthritis in Britain and 50 million in the US are almost 50 per cent more likely to end up with COPD, researchers at the University of British Columbia found. (Source: the Mail online | Health)
Source: the Mail online | Health - October 20, 2017 Category: Consumer Health News Source Type: news

Rheumatoid arthritis may increase COPD risk
New research demonstrates an association Related items fromOnMedica COPD led to 3.2m deaths in 2015 worldwide Certain occupations linked to increased risk of rheumatoid arthritis Rheumatoid arthritis Diagnosis of COPD needs to be improved Physical activity decreases risk of dying in COPD (Source: OnMedica Latest News)
Source: OnMedica Latest News - October 20, 2017 Category: UK Health Source Type: news

In RA, COPD Admissions Rise (CME/CE)
(MedPage Today) -- Patients with rheumatoid arthritis had a 47% increased risk of hospitalization for COPD (Source: MedPage Today Pulmonary)
Source: MedPage Today Pulmonary - October 19, 2017 Category: Respiratory Medicine Source Type: news

Zoo cure heals humans
One of the highlights of my trip to Tanzania in 2012 was visiting the Ngorongoro Crater and Conservation Area. They have the largest lions on the planet. I got very close as part of my invitation by the director of park services. Along with elephants, lions, gazelles and zebras, I got to see wildebeest, the almost-extinct black rhino and giraffes. I was lucky enough to photograph this giraffe on my trip to Ngorongoro Crater in Tanzania. I am always awed when I see these magnificent creatures in their native environment. They thrive the same way they did thousands of years ago. But when these animals are tak...
Source: Al Sears, MD Natural Remedies - October 19, 2017 Category: Complementary Medicine Authors: Cathy Card Tags: Anti-Aging Source Type: news

Arthritis symptoms: THREE unlikely signs of the joint condition REVEALED
ARTHRITIS symptoms are commonly thought of as joint pain and swelling, but noisy joints, muscle loss and dry eyes can also be signs you ’re suffering from rheumatoid arthritis or osteoarthritis. (Source: Daily Express - Health)
Source: Daily Express - Health - October 19, 2017 Category: Consumer Health News Source Type: news

Rheumatoid Arthritis linked to an increased risk of COPD
(Wiley) New research suggests that rheumatoid arthritis may increase the risk of developing chronic obstructive pulmonary disease (COPD). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 19, 2017 Category: International Medicine & Public Health Source Type: news

Are Hidradenitis and Rheumatoid Arthritis Related?
Title: Are Hidradenitis and Rheumatoid Arthritis Related?Category: Doctor's& Expert's views on SymptomsCreated: 10/17/2017 12:00:00 AMLast Editorial Review: 10/17/2017 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - October 17, 2017 Category: Rheumatology Source Type: news

Housecall: The importance of a healthy mouth
THIS WEEK'S TOP STORIES Oral health: A window to your overall health? Did you know that problems in your mouth can affect the rest of your body? Poor oral health might contribute to many diseases and conditions, including cardiovascular disease, premature birth and low birth weight, rheumatoid arthritis, and eating disorders. Learn more about why [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - October 16, 2017 Category: Databases & Libraries Source Type: news

Rheumatoid arthritis symptoms CURED with 'jelly' treatment that STOPS joint pain
RHEUMATOID arthritis symptoms could be relieved after scientists created a new, jelly-like treatment for the condition. (Source: Daily Express - Health)
Source: Daily Express - Health - October 13, 2017 Category: Consumer Health News Source Type: news

Medical News Today: Rheumatoid arthritis could be treated with a novel hydrogel
Researchers have developed a hydrogel that has the potential to treat rheumatoid arthritis by absorbing the excess fluid that builds up in joints. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 13, 2017 Category: Consumer Health News Tags: Arthritis / Rheumatology Source Type: news

What is rheumatoid arthritis? Symptoms, causes and treatment of condition REVEALED
RHEUMATOID arthritis is a serious condition that affects the joints. Here are the causes, symptoms and treatment of the disease. (Source: Daily Express - Health)
Source: Daily Express - Health - October 12, 2017 Category: Consumer Health News Source Type: news

Gel to fight rheumatoid arthritis
(Institute for Basic Science) IBS scientists developed a potentially therapeutic gel, which detects nitric oxide, absorbs excess fluids and delivers drugs. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 11, 2017 Category: International Medicine & Public Health Source Type: news

Arthritis on the agenda at party conferences
The policy, public affairs and campaigns team (PPA) has been raising recognition of arthritis at four key political party conferences: Liberal Democrats, Labour, Conservatives and the Scottish National Party.Alongside our Chief Executive, Liam O’Toole, staff attended various high profile events and round tables, and for the first time, at Labour and Conservative conferences, we also had an exhibition stand:showcasing hard hitting stats about the impact of arthritisproviding copies of ourPrevent, Transform, Cure manifesto, with key asks for MPsproviding local statistics for MPs to learn about prevalence in their ...
Source: Arthritis Research UK - October 10, 2017 Category: Rheumatology Source Type: news

Namibia: Battling With Rheumatoid Arthritis
[New Era] Windhoek -Six years ago, 25-year-old Ndapanda Sakaria was diagnosed with rheumatoid arthritis, after close to a year of being sick. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - October 10, 2017 Category: African Health Source Type: news

Stop Your Body Attacking Itself
Modern medicine has no cure for autoimmune diseases — and, sadly, most doctors don’t understand them. I’m talking about disorders like rheumatoid arthritis, type 1 diabetes, lupus, fibromyalgia, chronic fatigue syndrome, psoriasis, multiple sclerosis (MS) and more. In all, there are about 80 autoimmune diseases affecting organs throughout the body. They occur when your own immune system becomes overactive and attacks your body instead of diseases and foreign invaders. The standard mainstream treatment for most autoimmune disorders relies on Big Pharma drugs that cover up symptoms or suppress your immun...
Source: Al Sears, MD Natural Remedies - October 5, 2017 Category: Complementary Medicine Authors: Al Sears Tags: Anti-Aging Source Type: news

Godly gift for arthritis pain
Big Pharma is at it again… Creating and selling a drug that causes thousands of heart attacks and strokes each year. In 2015, the FDA asked drug makers to strengthen their warning labels. Since then, most have listed their dangerous side effects on the bottle. But one manufacturer thought they didn’t have to warn people about their dangerous drug. They marketed their product as a “unique” breakthrough. They even published studies promising it was “safe for long-term use.” 1 The drug is a 7-year-old arthritis drug called Actemra. It’s made by the Swiss pharmaceutical company Roche....
Source: Al Sears, MD Natural Remedies - October 5, 2017 Category: Complementary Medicine Authors: Al Sears Tags: Anti-Aging Source Type: news

New Qualcomm Patch Can Monitor Patients for Cheaper than Lunch at a Fast Food Joint
Qualcomm Life, the healthcare subsidiary of telecom giant Qualcomm Inc., yesterday announced that it has developed reference designs for single-use, connected, medical-grade biometric patches that will be commercially available in 2018. Details in a press release about the patches were scant, but James Mault, MD, FACS, senior vice president and chief medical officer at Qualcomm Life provided a few specifics Tuesday during a panel discussion at the Medtech Conference hosted by industry trade group AdvaMed in San Jose. The Bluetooth Low Energy–enabled patches have a seven-day battery life and can measure motion, heart ...
Source: MDDI - September 28, 2017 Category: Medical Devices Authors: Jamie Hartford Tags: Digital Health Adhesives, Electronics Source Type: news

AbbVie, Amgen settlement sets Humira U.S. biosimilar launch for 2023
(Reuters) - Amgen Inc has reached a settlement with AbbVie Inc that will delay the U.S. launch of Amgen's cheaper biosimilar version of AbbVie's cash cow, the blockbuster rheumatoid arthritis drug Humira, until Jan. 31, 2023, the companies said on Thursday. (Source: Reuters: Health)
Source: Reuters: Health - September 28, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

RA Activity Stable After Prolonging Adalimumab Interval RA Activity Stable After Prolonging Adalimumab Interval
Reducing the frequency of adalimumab did not worsen disease activity or function in patients with rheumatoid arthritis and may safely lower treatment costs and risks for adverse events, a study found.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 27, 2017 Category: Consumer Health News Tags: Rheumatology News Source Type: news

FDA rejects J & J application for new rheumatoid arthritis treatment
Janssen Biotech ’s biologics license application for an experimental arthritis therapy it's developing was rejected by the Food and Drug Administration Horsham-based Janssen Biotech, a subsidiary of Johnson& Johnson (NYSE: JNJ), was seeking approval for sirukumab as a treatment for moderately-to-severely active rheumatoid arthritis. The FDA said additional clinical data are needed to further evaluate the safety of the new drug candidate. “We are disappointed by this development as we feel… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - September 25, 2017 Category: Health Management Authors: John George Source Type: news

No Rise in Lymphoma Risk with Tofacitinib (CME/CE)
(MedPage Today) -- In patients with rheumatoid arthritis, rates were what is expected with immunomodulators (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - September 25, 2017 Category: Rheumatology Source Type: news

Digital tomo refines postoperative imaging of hand fractures
The proper installation of orthopedic hardware in the hand and wrist after...Read more on AuntMinnie.comRelated Reading: Which orthopedic imaging options are the safest? Digital tomosynthesis works well for spinal tuberculosis DR tomosynthesis gives wrist radiography a hand DR tomo holds promise for fungal pneumonia surveillance Tomosynthesis nearly equals MRI for rheumatoid arthritis (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 25, 2017 Category: Radiology Source Type: news